Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127152561 | 12715256 | 1 | I | 20151226 | 20160906 | 20160906 | PER | PL-LUPIN PHARMACEUTICALS INC.-2016-00041 | LUPIN | SCHETZ D, KOCIC I. A NEW ADVERSE DRUG REACTION - SCHAMBERG^S DISEASE CAUSED BY AMLODIPINE ADMINISTRATION - A CASE REPORT. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2015 DEC;80(6):1477-1478. | 31.00 | YR | M | Y | 0.00000 | 20160906 | MD | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127152561 | 12715256 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNKNOWN | 78043 | 10 | MG | QD | |||||||
| 127152561 | 12715256 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNKNOWN | 78043 | ||||||||||
| 127152561 | 12715256 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127152561 | 12715256 | 1 | Essential hypertension |
| 127152561 | 12715256 | 3 | Essential hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127152561 | 12715256 | Chronic pigmented purpura | |
| 127152561 | 12715256 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |